Low Laser Therapy and Hyaluronic Acid as an Adjunct to Non-surgical Periodontal Therapy
- Conditions
- Periodontitis
- Interventions
- Device: SRP+HADevice: SRPDevice: SRP+LASER (Dentsply Sirona - SIROLaser Blue)
- Registration Number
- NCT05907161
- Lead Sponsor
- University of Ljubljana
- Brief Summary
Periodontal disease is an oral disease characterized by microbially associated, host-mediated inflammation of the periodontium. In the treatment of periodontal disease, conventional periodontal therapy includes both surgical and non-surgical approaches. Non-surgical therapy (i.e. scaling and root planing - SRP) remains an essential part of periodontal therapy. Here, diseased root surface debridement utilizing different hand and ultrasonic instrumentation is performed to facilitate periodontal re-attachment and to reduce the bacterial mass in the periodontal pocket.
In the last decade, the use of lasers (light amplification by stimulated emission of radiation) has occupied part of the dialogue within periodontology due to several proposed advantages. In the arena of periodontology, laser use, as an adjunct to non-surgical therapy, was demonstrated to enhance periodontal healing; however, it is still the matter of debate. Among laser applications, low-level laser therapy is recommended for its pain-reducing, woundhealing and anti-inflammatory effects.
Hyaluronic acid is a non-sulfated glycosaminoglycan and a major component of the extracellular matrix. It is found in various body fluids, such as gingival crevicular fluid, saliva, serum and synovial fluid. Anti-inflammatory, anti-edematous and anti-bacterial activities of hyaluronic acid have been investigated in dentistry, specially in periodontology.
- Detailed Description
Each participant will be assigned in one of three groups. In each group there will be 15 participants. Different treatment protocols will be carried in each group as follows: group one (scaling and root planing), group two (scaling and root planing + LASER), group three (scaling and root planing + hyaluronic acid). Under local anesthesia we will perform scaling and root planing of the teeth in two sessions. The procedure be made with the use of ultrasonic (PiezoLED Scaler, KaVo, Biberach, DE) and hand instruments (Gracey, Hu Friedy, Chicago, IL, USA). In group one, only scaling and root planning (SRP) will be made. In group two, the use of a diode laser (Dentsply Sirona - SIROLaser Blue) will be added to the therapy. In group three, after the performance of SRP, a gel containing hyaluronic acid (Regedent, HyaDENT Cross linked hyaluronic acid gel) will be applied intrasulcular.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 45
- systemically healthy
- nonsmokers
- untreated periodontal disease (stage 3, grade B or C)
- plaque index will not exceed 20%
- at least 20 teeth in oral cavity
- systemic diseases with impact on periodontal health
- medication with impact on periodontal health
- smokers
- pregnant and lactating women
- patients treated with antibiotics in the last 12 months
- patients who had undergone periodontal treatment in the last year
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description SRP+HA SRP+HA The SRP+HA group will receive non-surgical periodontal therapy using an ultrasonic device and curettes in two sessions. After session 2, a gel containing hyaluronic acid (Regedent, HyaDENT Cross linked hyaluronic acid gel) will be applied intrasulcular to all sites with PD ≥ 4mm. SRP SRP The SRP group will receive non-surgical periodontal therapy using an ultrasonic device and curettes in two sessions. SRP+LASER SRP+LASER (Dentsply Sirona - SIROLaser Blue) The SRP+LASER group will receive non-surgical periodontal therapy using an ultrasonic device and curettes in two sessions. After session 2, irradiation with a diode laser (Dentsply Sirona - SIROLaser Blue) will be applied intrasulcular to all sites with PD ≥ 4mm.
- Primary Outcome Measures
Name Time Method Probing pocket depth reduction 3 months, 6 months Change in probing pocket depth after treatment
- Secondary Outcome Measures
Name Time Method Clinical attachment level gain 3 months, 6 months Change in clinical attachment level after treatment
Residual diseased site number 3 months, 6 months No of sites with PD ≥ 4mm and bleeding on probing after treatment
Bleeding on probing percentage reduction 3 months, 6 months Bleeding after measurement of pocket depth, reduction after treatment
Trial Locations
- Locations (1)
Univerity Medical Center Ljubljana
🇸🇮Ljubljana, Slovenia